These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 2680495

  • 1. Myocardial and vascular actions of milrinone.
    Colucci WS.
    Eur Heart J; 1989 Aug; 10 Suppl C():32-8. PubMed ID: 2680495
    [Abstract] [Full Text] [Related]

  • 2. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
    Jaski BE, Fifer MA, Wright RF, Braunwald E, Colucci WS.
    J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
    [Abstract] [Full Text] [Related]

  • 3. Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique.
    Ludmer PL, Wright RF, Arnold JM, Ganz P, Braunwald E, Colucci WS.
    Circulation; 1986 Jan; 73(1):130-7. PubMed ID: 3940664
    [Abstract] [Full Text] [Related]

  • 4. Acute effects of intravenous milrinone in heart failure.
    Rettig GF, Schieffer HJ.
    Eur Heart J; 1989 Aug; 10 Suppl C():39-43. PubMed ID: 2680496
    [Abstract] [Full Text] [Related]

  • 5. Observations on the intracoronary administration of milrinone and dobutamine to patients with congestive heart failure.
    Colucci WS.
    Am J Cardiol; 1989 Jan 03; 63(2):17A-22A. PubMed ID: 2909993
    [Abstract] [Full Text] [Related]

  • 6. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS, Wright RF, Jaski BE, Fifer MA, Braunwald E.
    Circulation; 1986 Mar 03; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic achievements of phosphodiesterase inhibitors and the future.
    Jewitt DE.
    Eur Heart J; 1989 Aug 03; 10 Suppl C():53-9. PubMed ID: 2680498
    [Abstract] [Full Text] [Related]

  • 8. Effects of milrinone on systemic hemodynamics and regional circulations in dogs with congestive heart failure: comparison with dobutamine.
    Liang CS, Thomas A, Imai N, Stone CK, Kawashima S, Hood WB.
    J Cardiovasc Pharmacol; 1987 Nov 03; 10(5):509-16. PubMed ID: 2447398
    [Abstract] [Full Text] [Related]

  • 9. Effects of milrinone on left ventricular performance and myocardial contractility in patients with severe heart failure.
    Sonnenblick EH, Grose R, Strain J, Zelcer AA, LeJemtel TH.
    Circulation; 1986 Mar 03; 73(3 Pt 2):III162-7. PubMed ID: 3510772
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Milrinone. A preliminary review of its pharmacological properties and therapeutic use.
    Young RA, Ward A.
    Drugs; 1988 Aug 03; 36(2):158-92. PubMed ID: 3053125
    [Abstract] [Full Text] [Related]

  • 12. Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition.
    Colucci WS, Denniss AR, Leatherman GF, Quigg RJ, Ludmer PL, Marsh JD, Gauthier DF.
    J Clin Invest; 1988 Apr 03; 81(4):1103-10. PubMed ID: 2832444
    [Abstract] [Full Text] [Related]

  • 13. Milrinone: basic and clinical pharmacology and acute and chronic management.
    Shipley JB, Tolman D, Hastillo A, Hess ML.
    Am J Med Sci; 1996 Jun 03; 311(6):286-91. PubMed ID: 8659556
    [Abstract] [Full Text] [Related]

  • 14. Effect of oral milrinone on end-systolic relations in patients with severe congestive heart failure.
    Miller WP, Ark CR, Wiederholt P.
    Am J Cardiol; 1987 Oct 01; 60(10):842-6. PubMed ID: 3661398
    [Abstract] [Full Text] [Related]

  • 15. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone.
    Monrad ES, McKay RG, Baim DS, Colucci WS, Fifer MA, Heller GV, Royal HD, Grossman W.
    Circulation; 1984 Dec 01; 70(6):1030-7. PubMed ID: 6499142
    [Abstract] [Full Text] [Related]

  • 16. Pharmacology of positive inotropic phosphodiesterase III inhibitors.
    Honerjäger P.
    Eur Heart J; 1989 Aug 01; 10 Suppl C():25-31. PubMed ID: 2553411
    [Abstract] [Full Text] [Related]

  • 17. Identification of the direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failure.
    Cody RJ, Müller FB, Kubo SH, Rutman H, Leonard D.
    Circulation; 1986 Jan 01; 73(1):124-9. PubMed ID: 3940663
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure.
    Baim DS, McDowell AV, Cherniles J, Monrad ES, Parker JA, Edelson J, Braunwald E, Grossman W.
    N Engl J Med; 1983 Sep 29; 309(13):748-56. PubMed ID: 6888453
    [Abstract] [Full Text] [Related]

  • 19. Milrinone in heart failure. Acute effects on left ventricular systolic function and myocardial metabolism.
    Timmis AD, Smyth P, Monaghan M, Walker L, Daly K, McLeod AA, Jewitt DE.
    Br Heart J; 1985 Jul 29; 54(1):36-41. PubMed ID: 4015914
    [Abstract] [Full Text] [Related]

  • 20. [The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside].
    Domínguez de Rozas JM, Guindo Soldevila J, Rodríguez Font E, Martínez Vílchez R.
    Rev Esp Cardiol; 1994 Oct 29; 47(10):682-6. PubMed ID: 7991922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.